ロード中...
Pancreatic Cancer Metastasis: Are we being Pre-EMTed?
Pancreatic cancer, often considered a metastatic disease at the time of clinical diagnosis due to lack of any reliable early diagnostic marker(s), is refractory to conventional chemo- and radiotherapy and has a dismal 5-year survival rate of only 6%. Although surgical removal of the primary tumor is...
保存先:
| 出版年: | Curr Pharm Des |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4457289/ https://ncbi.nlm.nih.gov/pubmed/25506899 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|